These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11894215)

  • 41. Salvage of thrombosed polytetrafluoroethylene dialysis fistulas by interposition grafting.
    Wellington JL
    Can J Surg; 1983 Sep; 26(5):463-5. PubMed ID: 6616365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PTFE shunts for hemodialysis access: progressive choice of configuration.
    Santoro TD; Cambria RA
    Semin Vasc Surg; 1997 Sep; 10(3):166-74. PubMed ID: 9304734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Vascular access lines: use of biologic grafts].
    Bitker MO; Rottembourg J; Chatelain C
    Ann Urol (Paris); 1985; 19(4):225-7. PubMed ID: 4026215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manual thromboaspiration and dilation of thrombosed dialysis access: mid-term results of a simple concept.
    Turmel-Rodrigues L; Sapoval M; Pengloan J; Billaux L; Testou D; Hauss S; Mouton A; Blanchard D
    J Vasc Interv Radiol; 1997; 8(5):813-24. PubMed ID: 9314373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Surgical management of dysfunctions of dialysis fistulas].
    Wahl W; Bredel J; Wandel E; Schnütgen M; Mann M; Junginger T
    Langenbecks Arch Chir; 1997; 382(5):237-42. PubMed ID: 9411169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter evaluation of a polyurethaneurea vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications.
    Glickman MH; Stokes GK; Ross JR; Schuman ED; Sternbergh WC; Lindberg JS; Money SM; Lorber MI
    J Vasc Surg; 2001 Sep; 34(3):465-72; discussion 472-3. PubMed ID: 11533599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salvage of upper arm access grafts by extension to the infraclavicular axillary vein.
    Dubner S; Weinbaum FI
    Am J Surg; 1987 Apr; 153(4):407-8. PubMed ID: 3565688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular access for hemodialysis. Patency rates and results of revision.
    Palder SB; Kirkman RL; Whittemore AD; Hakim RM; Lazarus JM; Tilney NL
    Ann Surg; 1985 Aug; 202(2):235-9. PubMed ID: 4015229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access.
    Sorom AJ; Hughes CB; McCarthy JT; Jenson BM; Prieto M; Panneton JM; Sterioff S; Stegall MD; Nyberg SL
    Surgery; 2002 Aug; 132(2):135-40. PubMed ID: 12219003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Stenosis of hemodialysis grafts. Treatment with a short graft].
    Valverde JP; Maillet R; Nussaume O
    Presse Med; 1984 Sep; 13(32):1957-8. PubMed ID: 6237345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term follow-up of the polytetrafluoroethylene (PTFE) prosthesis as an arteriovenous fistula for haemodialysis.
    Tordoir JH; Herman JM; Kwan TS; Diderich PM
    Eur J Vasc Surg; 1988 Feb; 2(1):3-7. PubMed ID: 3224715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nosocomial graft fragmentation and healing response of an ePTFE angioaccess graft.
    Anderson JM; Hering TM; Ansel AL; Johnson JM
    J Biomed Mater Res; 1987 Aug; 21(A2 Suppl):153-62. PubMed ID: 3624284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early experience with a new ePTFE vascular prosthesis for hemodialysis.
    Bartlett ST; Schweitzer EJ; Roberts JE; Jaekels JL; Sandager GL; Johnson LB; Killewich LA
    Am J Surg; 1995 Aug; 170(2):118-22. PubMed ID: 7631914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Skin-flap coverage of polytetrafluoroethylene vascular access graft exposed by previous infection.
    Tellis VA; Weiss P; Matas AJ; Veith FJ
    Surgery; 1988 Jan; 103(1):118-21. PubMed ID: 3336861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pentosan polysulfate decreases proliferation and extracellular matrix deposition by vascular smooth muscle cells isolated from failed hemodialysis access grafts.
    Elliot SJ; Striker LJ; Connor E; Stetler-Stevenson W; McQuinn WC; Blagg CR; Striker GE
    Clin Nephrol; 2000 Aug; 54(2):121-7. PubMed ID: 10968687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preserved saphenous vein allografts for vascular access.
    Piccone VA; Sika J; Ahmed N; LeVeen HH; DiScala V
    Surg Gynecol Obstet; 1978 Sep; 147(3):385-90. PubMed ID: 684591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Straight upper arm arteriovenous implants of allogenic vascular transplant material in various hemodynamic conditions].
    Scholz H; Naundorf M; Precht K; Schulze BD; Röseler E; Buder HW; Matthes G; Schoepke W
    Zentralbl Chir; 1988; 113(7):441-5. PubMed ID: 3400362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythropoietin therapy improves graft patency with no increased incidence of thrombosis or thrombophlebitis.
    Martino MA; Vogel KM; O'Brien SP; Kerstein MD
    J Am Coll Surg; 1998 Dec; 187(6):616-9. PubMed ID: 9849735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Secondary procedures for A-V fistula failure.
    Kootstra G
    Proc Eur Dial Transplant Assoc; 1983; 19():99-105. PubMed ID: 6878269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arteriovenous fistula with bovine arterial grafts for hemodialysis.
    Vander Werf BA
    South Med J; 1975 Jun; 68(6):681-3. PubMed ID: 1169817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.